207 related articles for article (PubMed ID: 17587138)
1. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways.
Fuentes MK; Nigavekar SS; Arumugam T; Logsdon CD; Schmidt AM; Park JC; Huang EH
Dis Colon Rectum; 2007 Aug; 50(8):1230-40. PubMed ID: 17587138
[TBL] [Abstract][Full Text] [Related]
2. S100P promotes pancreatic cancer growth, survival, and invasion.
Arumugam T; Simeone DM; Van Golen K; Logsdon CD
Clin Cancer Res; 2005 Aug; 11(15):5356-64. PubMed ID: 16061848
[TBL] [Abstract][Full Text] [Related]
3. S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer.
Onyeagucha BC; Mercado-Pimentel ME; Hutchison J; Flemington EK; Nelson MA
Exp Cell Res; 2013 Aug; 319(13):2081-2090. PubMed ID: 23693020
[TBL] [Abstract][Full Text] [Related]
4. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.
Mercado-Pimentel ME; Onyeagucha BC; Li Q; Pimentel AC; Jandova J; Nelson MA
FEBS Lett; 2015 Aug; 589(18):2388-93. PubMed ID: 26193421
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231.
Sharaf H; Matou-Nasri S; Wang Q; Rabhan Z; Al-Eidi H; Al Abdulrahman A; Ahmed N
Biochim Biophys Acta; 2015 Mar; 1852(3):429-41. PubMed ID: 25514746
[TBL] [Abstract][Full Text] [Related]
6. S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE).
Arumugam T; Simeone DM; Schmidt AM; Logsdon CD
J Biol Chem; 2004 Feb; 279(7):5059-65. PubMed ID: 14617629
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
8. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
[TBL] [Abstract][Full Text] [Related]
9. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of S100P, receptor for advanced glycation end products and ezrin in malignant melanoma.
Zhu L; Ito T; Nakahara T; Nagae K; Fuyuno Y; Nakao M; Akahoshi M; Nakagawa R; Tu Y; Uchi H; Furue M
J Dermatol; 2013 Dec; 40(12):973-9. PubMed ID: 24303922
[TBL] [Abstract][Full Text] [Related]
11. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F; Sorci G; Donato R
J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
[TBL] [Abstract][Full Text] [Related]
12. The induction of S100p expression by the Prostaglandin E₂ (PGE₂)/EP4 receptor signaling pathway in colon cancer cells.
Chandramouli A; Mercado-Pimentel ME; Hutchinson A; Gibadulinová A; Olson ER; Dickinson S; Shañas R; Davenport J; Owens J; Bhattacharyya AK; Regan JW; Pastorekova S; Arumugam T; Logsdon CD; Nelson MA
Cancer Biol Ther; 2010 Nov; 10(10):1056-66. PubMed ID: 20890108
[TBL] [Abstract][Full Text] [Related]
13. Molecular regulation of S100P in human lung adenocarcinomas.
Rehbein G; Simm A; Hofmann HS; Silber RE; Bartling B
Int J Mol Med; 2008 Jul; 22(1):69-77. PubMed ID: 18575778
[TBL] [Abstract][Full Text] [Related]
14. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.
Arumugam T; Ramachandran V; Gomez SB; Schmidt AM; Logsdon CD
Clin Cancer Res; 2012 Aug; 18(16):4356-64. PubMed ID: 22718861
[TBL] [Abstract][Full Text] [Related]
15. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of receptor for advanced glycation end products attenuate 17α-ethinyl-estradiol dependent proliferation and survival of MCF-7 breast cancer cells.
Lata K; Mukherjee TK
Biochim Biophys Acta; 2014 Mar; 1840(3):1083-91. PubMed ID: 24252278
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation and functional implication of S100P in cancer.
Gibadulinova A; Tothova V; Pastorek J; Pastorekova S
Amino Acids; 2011 Oct; 41(4):885-92. PubMed ID: 20155429
[TBL] [Abstract][Full Text] [Related]
18. Domain I-IV of β2-glycoprotein I inhibits advanced glycation end product-induced angiogenesis by down-regulating vascular endothelial growth factor 2 signaling.
Wang QQ; Zhou SJ; Meng ZX; Wang J; Chen R; Lv L; Li CJ; Yu DM; Yu P
Mol Med Rep; 2015 Mar; 11(3):2167-72. PubMed ID: 25405610
[TBL] [Abstract][Full Text] [Related]
19. Interaction between S100P and the anti-allergy drug cromolyn.
Penumutchu SR; Chou RH; Yu C
Biochem Biophys Res Commun; 2014 Nov; 454(3):404-9. PubMed ID: 25450399
[TBL] [Abstract][Full Text] [Related]
20. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
